New compound advances into Phase 1 trial for pancreatic cancer
by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc
Updated on: April 09,2024
10

New compound advances into Phase 1 trial for pancreatic cancer
by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc
Updated on:April 09,2024
10
